Dr. David J. Harrison

Dr. Ari Cedars is a cardiologist in Baltimore, Maryland. He also serves as director of the Adult Congenital Heart Disease Center at both the Johns Hopkins Heart and Vascular Institute and the Blalock-Taussig-Thomas Pediatric and Congenital Heart Center. Dr. Cedars is an associate professor of medicine and pediatrics at the Johns Hopkins University School of Medicine. Dr. Cedars specializes in adult congenital heart disease. He is a member of the leadership committee for the Advanced Cardiac Therapies Improving Outcomes Network (ACTION), an organization focused on the improvement of outcomes for pediatric ventricular assist device (VAD) patients. He is an administrative board member of the Alliance for Adult Research in Congenital Cardiology (AARCC), a multi-institutional academic research network devoted to producing new research in adult congenital heart disease. He is also a member of the medical advisory board for the Adult Congenital Heart Association (ACHA). Dr. Cedars’ research focuses on patient-centered outcomes, mechanical circulatory support and ventricular assist devices, and the biological mechanisms underlying clinical disease progression in congenital heart disease. Dr. Cedars is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Congenital Heart Disease (CHD), Tetralogy of Fallot, Heart Attack, Apoplexy, and Heart Transplant. Dr. Cedars is board certified in American Board Of Internal Medicine.

Mary T. Donofrio, MD, FAAP, FACC, FASE, is a professor of pediatrics at George Washington University School of Medicine and is a pediatric and fetal cardiologist at Children's National Hospital in Washington D.C. She is the VanMetre Companies endowed chair of fetal cardiology and is medical director of Prenatal Cardiology, director of the Critical Care Delivery Program and Advanced Cardiac Imaging Fellowship, and co-director of the Cardiac Neurodevelopmental Outcome Program. She is the founding president of the Fetal Heart Society, a non-profit international organization created to advance the field of fetal cardiovascular care and science through collaborative research, education and mentorship. Dr. Donofrio is an international expert in fetal cardiology and is known for her work in establishing multidisciplinary protocols for specialized delivery room management of babies diagnosed in utero with complex congenital heart disease. She has collaborated with scientists in the field to study how alterations in the fetal circulation affect in utero brain development as well as to investigate potential treatment strategies to improve neurodevelopmental outcome in babies with congenital heart disease. She has published over 150 papers, including the American Heart Association Scientific Statement on the Diagnosis and Treatment of Fetal Cardiac Disease, the American Society of Echocardiography Guidelines and Recommendations for Performance of the Fetal Echocardiogram, and the Call to Action Report on Prioritizing Delivery Room Care for Neonates with Critical Congenital Heart Disease. Publications: PUBMED. Dr. Donofrio is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Congenital Heart Disease (CHD), Double Aortic Arch, Vascular Ring, Ebstein's Anomaly, and Septoplasty. Dr. Donofrio is board certified in Pediatric Cardiology: American Board Of Pediatrics, 1996.

Ashraf Harahsheh, MD, FACC, FAAP, joined Children’s National Hospital in September 2008 as a full-time attending. He is currently the director of the Kawasaki Disease Program and Cardiology Resident Education and is active in inpatient and outpatient care, as well in the Preventive Cardiology Program with a focus on hyperlipidemia. Dr. Harahsheh completed his fellowship training at the Children’s Hospital of Michigan, Wayne State University School of Medicine, Detroit, Mich. Dr. Harahsheh is board certified in pediatric cardiology. He is a fellow of the American Academy of Pediatrics and the American College of Cardiology and a member of the National Lipid Association and the Academic Pediatric Association. Dr. Harahsheh received his doctorate of medicine from the University of Jordan-College of Medicine, Amman, Jordan. He is an active member of the Joint Council on Congenital Heart Disease’s National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC). His research interests include resource utilization, quality improvement and development of new educational programs teaching the next generation of providers communication skills surrounding subspecialty referral. Dr. Harahsheh sees patients at the Children’s National main campus, Children's National Annapolis, Children's National Upper Marlboro, Cardiology Clinic at Charlotte Hall, Md., and Virginia Hospital Center in Arlington, Va. Dr. Harahsheh’s recent honors and awards include: 2016-2017 Who’s Who in Science and Engineering (Marquis Who’s Who Publications) Top 10 Cardiologist 2014 (Vitals) 2014 ACC Teaching Skills Workshop for Emerging Faculty Course Guide to America’s Top Pediatricians 2014 Edition (Consumer’s Research Council of America) 2014 Honorable Mention in Education (Children’s National Health System) 2017 Certificate of Excellence at the Seventh Annual Children's National Health System Research and Education Week. Dr. Harahsheh is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coronary Artery Aneurysm, Pediatric Myocarditis, and Heart Transplant. Dr. Harahsheh is board certified in Pediatric Cardiology: American Board Of Pediatrics, 2008 and Pediatrics: American Board Of Pediatrics, 2004.